Mark Wilterding | VP, IR |
Mike Mussallem | Chairman & CEO |
Scott Ullem | CFO |
Bob Hopkins | Bank of America Merrill Lynch |
David Lewis | Morgan Stanley |
Raj Denhoy | Jefferies |
Larry Biegelsen | Wells Fargo |
Kristen Stewart | Barclays |
Jason Mills | Canaccord Genuity |
Robbie Marcus | JPMorgan |
Matt Taylor | UBS |
Vijay Kumar | Evercore ISI |
Suraj Kalia | Oppenheimer & Company |
Rick Wise | Stifel |
Danielle Antalffy | SVB Leerink |
Pito Chickering | Deutsche Bank |
Matt Miksic | Credit Suisse |
Greetings, welcome to the Edwards Lifesciences Fourth Quarter 2019 Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the presentation. [Operator Instructions] Please note this conference call is being recorded.
I would now turn the conference over to our host, Mark Wilterding, Vice President of Investor Relations.